Page last updated: 2024-10-30

metaproterenol and Carcinoma, Renal Cell

metaproterenol has been researched along with Carcinoma, Renal Cell in 1 studies

Metaproterenol: A beta-2 adrenergic agonist used in the treatment of ASTHMA and BRONCHIAL SPASM.
orciprenaline : A racemate composed of equimolar amounts of (R)- and (S)-orciprenaline. Used (as its sulfate salt) to relax the airway muscles and improve breathing for patients suffering from asthma or bronchitis.
5-[1-hydroxy-2-(isopropanylamino)ethyl]benzene-1,3-diol : A member of the class of resorcinols bearing an additional 1-hydroxy-2-(isopropanylamino)ethyl substituent at position 5 of resorcinol itself.

Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanisawa, M1

Other Studies

1 other study available for metaproterenol and Carcinoma, Renal Cell

ArticleYear
[Pathogenesis of human cancer development due to environmental factors].
    Gan no rinsho. Japan journal of cancer clinics, 1984, Volume: 30, Issue:12 Suppl

    Topics: Adult; Aflatoxin B1; Aflatoxins; Animals; Bronchi; Carcinogens; Carcinoma, Hepatocellular; Carcinoma

1984